Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,106 Gastrointestinal
clinical trials

Gastroenterology Clinical Trial
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis [EXPEDITION]
Status: Enrolling, Phase II
Updated: 12/31/1969
eStudySite
115
mi
from 91732
Chula Vista, CA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis [EXPEDITION]
Status: Enrolling, Phase II
Updated: 12/31/1969
American Research Institute, Inc.
2319
mi
from 91732
Cutler Bay, FL
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis [EXPEDITION]
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Partners
2268
mi
from 91732
Richmond, VA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Southwest Oncology PC
609
mi
from 91732
Durango, CO
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Swedish Medical Center-Edmonds
974
mi
from 91732
Edmonds, WA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Elizabeth Hospital
930
mi
from 91732
Enumclaw, WA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Luke's Mountain States Tumor Institute - Fruitland
688
mi
from 91732
Fruitland, ID
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Wayne Memorial Hospital
2258
mi
from 91732
Goldsboro, NC
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Benefis Healthcare- Sletten Cancer Institute
991
mi
from 91732
Great Falls, MT
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
CHI Saint Vincent Cancer Center Hot Springs
1421
mi
from 91732
Hot Springs, AR
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Swedish Cancer Institute-Issaquah
952
mi
from 91732
Issaquah, WA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Luke's Hospital, Kansas City
1340
mi
from 91732
Kansas City, MO
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Research Medical Center
1341
mi
from 91732
Kansas City, MO
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
CHI Health Good Samaritan
1132
mi
from 91732
Kearney, NE
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Providence Regional Cancer System-Lacey
928
mi
from 91732
Lacey, WA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Rocky Mountain Cancer Centers-Lakewood
808
mi
from 91732
Lakewood, CO
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Longmont United Hospital
825
mi
from 91732
Longmont, CO
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Rocky Mountain Cancer Centers-Longmont
824
mi
from 91732
Longmont, CO
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Illinois CancerCare - Macomb
1559
mi
from 91732
Macomb, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Hennepin County Medical Center
1511
mi
from 91732
Minneapolis, MN
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Health Partners Inc
1510
mi
from 91732
Minneapolis, MN
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Creighton University Medical Center
1299
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Illinois CancerCare-Ottawa Clinic
1662
mi
from 91732
Ottawa, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Parker Adventist Hospital
823
mi
from 91732
Parker, CO
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Methodist Medical Center of Illinois
1617
mi
from 91732
Peoria, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Kaiser Permanente Northwest
829
mi
from 91732
Portland, OR
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Kootenai Cancer Center
944
mi
from 91732
Post Falls, ID
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Washington University School of Medicine
1569
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Springfield Clinic
1608
mi
from 91732
Springfield, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Medical Center
1608
mi
from 91732
Springfield, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Carle Cancer Center
1685
mi
from 91732
Urbana, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Mercy Medical Center-West Lakes
1415
mi
from 91732
West Des Moines, IA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Baylor College of Medicine
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Digestive Disease Associates, PA
2295
mi
from 91732
Catonsville, MD
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Houston Methodist Hospital
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Premier Vein and Vascular Center
1339
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Gastrointestinal Biosciences
22
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Arkansas Gastroenterology
1464
mi
from 91732
North Little Rock, AR
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Alliance Clinical Research
73
mi
from 91732
Oceanside, CA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Holland Center for Family Health
333
mi
from 91732
Peoria, AZ
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Inland Empire Liver Foundation
35
mi
from 91732
Rialto, CA
Click here to add this to my saved trials
Ventral Hernia Clinical Trial
Post Market Study of Parietene™ DS Composite Mesh in Ventral Hernia Repair
Status: Enrolling
Updated: 12/31/1969
Ohio State University
1959
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
Ventral Hernia Clinical Trial
Post Market Study of Parietene™ DS Composite Mesh in Ventral Hernia Repair
Status: Enrolling
Updated: 12/31/1969
Medical College of Wisconsin
1729
mi
from 91732
Milwaukee, WI
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Center for Advanced Gastroenterology
2182
mi
from 91732
Maitland, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
South Lake Pain Institute
2161
mi
from 91732
Clermont, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
American Research Institute, Inc.
2319
mi
from 91732
Cutler Bay, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Atlanta Center for Gastroenterology, P.C.
1924
mi
from 91732
Decatur, GA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Medisphere Medical Research Center
1717
mi
from 91732
Evansville, IN
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Trials of SW Louisiana LLC
1469
mi
from 91732
Lake Charles, LA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Southern California Research Institute Medical Group Inc
13
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Blue Ridge Medical Research
2176
mi
from 91732
Lynchburg, VA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Cotton-O'Neil Clinical Research Center, Digestive Health
1282
mi
from 91732
Topeka, KS
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Manual Therapy in Treating Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors
Status: Enrolling
Updated: 12/31/1969
M D Anderson Cancer Center
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Pediatric Acute Gastrointestinal Bleeding Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Boston Children's Hospital
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Pediatric Acute Gastrointestinal Bleeding Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Ann & Robert H. Lurie Children's Hospital of Chicago
1729
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Pediatric Acute Gastrointestinal Bleeding Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Texas Children's Hospital
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
University of North Carolina at Chapel Hill
2189
mi
from 91732
Chapel Hill, NC
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Cook Children's Medical Center
1193
mi
from 91732
Fort Worth, TX
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Investigational Study of Experimental Medication BMS-986165 in Patients With Moderate to Severe Crohn's Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Local Institution
1762
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Investigational Study of Experimental Medication BMS-986165 in Patients With Moderate to Severe Crohn's Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Donald Guthrie Foundation for Education and Research
2299
mi
from 91732
Sayre, PA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Investigational Study of Experimental Medication BMS-986165 in Patients With Moderate to Severe Crohn's Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Local Institution
963
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Investigational Study of Experimental Medication BMS-986165 in Patients With Moderate to Severe Crohn's Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Gastroenterology Associates of Western Michigan
1837
mi
from 91732
Wyoming, MI
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Treatment of Chronic Delta Hepatitis With Lonafarnib, Ritonavir and Lambda Interferon
Status: Enrolling, Phase II
Updated: 12/31/1969
National Institutes of Health Clinical Center
2277
mi
from 91732
Bethesda, MD
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Nephrology / Urology, Other Clinical Trial
Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI
Status: Enrolling, Phase II
Updated: 12/31/1969
Kidney & Hypertension Specialists
1188
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
Status: Enrolling, Phase
Updated: 12/31/1969
Massachusetts General Hospital
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Other Clinical Trial
Blood Markers of Early Pancreas Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
Nebraska Medical Center
1289
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology Clinical Trial
Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of Texas Southwestern
1221
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Prospective Evaluation of the Efficacy and Safety of Submucosal Endoscopy
Status: Enrolling, Phase
Updated: 12/31/1969
University of Colorado Hospital
825
mi
from 91732
Aurora, CO
Click here to add this to my saved trials
Hyperbilirubinemia Clinical Trial
Validity of Transcutaneous Bilirubin Monitoring in Preterm Infants
Status: Enrolling, Phase
Updated: 12/31/1969
Banner - University Medical Center Phoenix
344
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials
Adenomatous Polyposis Coli Clinical Trial
A Study of Guselkumab in Participants With Familial Adenomatous Polyposis
Status: Enrolling, Phase I
Updated: 12/31/1969
Cleveland Clinic
2035
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Adenomatous Polyposis Coli Clinical Trial
A Study of Guselkumab in Participants With Familial Adenomatous Polyposis
Status: Enrolling, Phase I
Updated: 12/31/1969
Fox Chase Cancer Center
2379
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Baylor College of Medicine
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Chicago Medical Center
1730
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Pittsburgh Medical Center
2121
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
Gastroenterology, Pharmacology / Toxicology Clinical Trial
X-linked Hypophosphatemia Disease Monitoring Program
Status: Enrolling, Phase
Updated: 12/31/1969
The Ohio State University, Wexner Medical Center
1960
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
Gastroenterology, Pharmacology / Toxicology Clinical Trial
X-linked Hypophosphatemia Disease Monitoring Program
Status: Enrolling, Phase
Updated: 12/31/1969
Yale University School of Medicine
2486
mi
from 91732
New Haven, CT
Click here to add this to my saved trials
Gastroenterology, Pharmacology / Toxicology Clinical Trial
X-linked Hypophosphatemia Disease Monitoring Program
Status: Enrolling, Phase
Updated: 12/31/1969
Seattle Children's Hospital
964
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Oregon Health and Science University
827
mi
from 91732
Portland, OR
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Providence Regional Cancer System-Aberdeen
941
mi
from 91732
Aberdeen, WA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Community Hospital of Anaconda
871
mi
from 91732
Anaconda, MT
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Alaska Oncology and Hematology LLC
2341
mi
from 91732
Anchorage, AK
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Anchorage Oncology Centre
2341
mi
from 91732
Anchorage, AK
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Alphonsus Cancer Care Center-Boise
664
mi
from 91732
Boise, ID
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Providence Saint Joseph Medical Center-Disney Family Cancer Center
18
mi
from 91732
Burbank, CA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Illinois CancerCare - Canton
1594
mi
from 91732
Canton, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Medical Oncology and Hematology Associates-West Des Moines
1415
mi
from 91732
Clive, IA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Kootenai Medical Center
941
mi
from 91732
Coeur d'Alene, ID
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Penrose-Saint Francis Healthcare
802
mi
from 91732
Colorado Springs, CO
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Rocky Mountain Cancer Centers-Penrose
804
mi
from 91732
Colorado Springs, CO
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Bay Area Hospital
722
mi
from 91732
Coos Bay, OR
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Decatur Memorial Hospital
1645
mi
from 91732
Decatur, IL
Click here to add this to my saved trials
Primary Biliary Cholangitis Clinical Trial
ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Baylor College of Medicine
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Primary Biliary Cholangitis Clinical Trial
ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Minnesota Medical Center, Fairview
1511
mi
from 91732
Minneapolis, MN
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Pediatric Longitudinal Cohort Study of Chronic Pancreatitis
Status: Enrolling, Phase
Updated: 12/31/1969
Massachusetts General Hospital
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Pediatric Longitudinal Cohort Study of Chronic Pancreatitis
Status: Enrolling, Phase
Updated: 12/31/1969
Childrens Hospital Los Angeles
15
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Pediatric Longitudinal Cohort Study of Chronic Pancreatitis
Status: Enrolling, Phase
Updated: 12/31/1969
Riley Hospital for Children, Indiana University
1793
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Pediatric Longitudinal Cohort Study of Chronic Pancreatitis
Status: Enrolling, Phase
Updated: 12/31/1969
Stanford University
328
mi
from 91732
Stanford, CA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Gastroparesis Registry 3
Status: Enrolling, Phase
Updated: 12/31/1969
Johns Hopkins Bayview Medical Center
2304
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Gastroparesis Registry 3
Status: Enrolling, Phase
Updated: 12/31/1969
University of Louisville
1812
mi
from 91732
Louisville, KY
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Connecticut Children's Medical Center
2497
mi
from 91732
Hartford, CT
Click here to add this to my saved trials
1 … 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 … 101